DB Fitzpatrick & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.9M Sell
3,788
-76
-2% -$36.5K 1.53% 14
2026
Q1
$1.9M Buy
3,864
+92
+2% +$49.9K 1.63% 9
2025
Q4
$2.19M Sell
3,772
-60
-2% -$33.9K 1.94% 8
2025
Q3
$1.86M Sell
3,832
-66
-2% -$30.7K 1.68% 9
2025
Q2
$1.58M Buy
3,898
+649
+20% +$271K 1.4% 15
2025
Q1
$1.62M Sell
3,249
-359
-10% -$194K 1.54% 10
2024
Q4
$1.88M Buy
3,608
+256
+8% +$141K 1.73% 11
2024
Q3
$2.07M Sell
3,352
-46
-1% -$27.2K 1.82% 10
2024
Q2
$1.88M Sell
3,398
-21
-0.6% -$12K 1.74% 10
2024
Q1
$1.99M Sell
3,419
-58
-2% -$32.5K 1.82% 8
2023
Q4
$1.85M Buy
3,477
+522
+18% +$253K 1.77% 9
2023
Q3
$1.5M Buy
2,955
+79
+3% +$42.1K 1.6% 10
2023
Q2
$1.5M Sell
2,876
-132
-4% -$71.2K 1.58% 13
2023
Q1
$1.73M Buy
3,008
+54
+2% +$30.4K 1.88% 11
2022
Q4
$1.63M Sell
2,954
-80
-3% -$42.4K 1.86% 10
2022
Q3
$1.54M Sell
3,034
-403
-12% -$226K 1.87% 7
2022
Q2
$1.87M Buy
3,437
+9
+0.3% +$4.95K 2.06% 6
2022
Q1
$2.02M Buy
3,428
+63
+2% +$36.2K 2.02% 7
2021
Q4
$2.25M Buy
+3,365
New +$2.1M 2.1% 7

Other funds holding TMO

DB Fitzpatrick & Co's TMO Position: Q2 2026 in Review

DB Fitzpatrick & Co reduced its Thermo Fisher Scientific (TMO) stake by 2% in Q2 2026, selling an estimated $36.5K and leaving 3,788 shares worth $1.9M. The position accounts for 1.53% of the portfolio, ranked #14.

DB Fitzpatrick & Co first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.25M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • DB Fitzpatrick & Co held 3,788 shares of Thermo Fisher Scientific worth $1.9M as of Q2 2026.
  • DB Fitzpatrick & Co sold 76 Thermo Fisher Scientific shares in Q2 2026, an estimated $36.5K.
  • Thermo Fisher Scientific made up 1.53% of DB Fitzpatrick & Co's portfolio in Q2 2026, its #14 holding.
  • DB Fitzpatrick & Co first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • DB Fitzpatrick & Co's Thermo Fisher Scientific position peaked at $2.25M in Q4 2021.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on DB Fitzpatrick & Co's 13F filing for Q2 2026, filed 15 Jul 2026.